Search Within

Mark Kris

  1. "Epidemiology and Biostatistics"
Formats
  1. Journal Article (93)
  2. Meeting Abstract (73)
  3. Conference Paper (1)
  4. Research Letter (1)
Groups
  1. Department of Medicine (168)
  2. Epidemiology and Biostatistics (168)
  3. Solid Tumor Oncology Division (168)
  4. Thoracic Oncology (168)
  5. Biostatistics Service (153)
  6. GSK Faculty (89)

More Groups

People
  1. Gregory Riely (62)
  2. Charles Rudin (53)
  3. Marc Ladanyi (51)
  4. Maria Arcila (40)
  5. Valerie Rusch (40)
  6. Helena Yu (39)

More People

Years
  1. 2025 (2)
  2. 2024 (6)
  3. 2023 (6)
  4. 2022 (9)
  5. 2021 (5)
  6. 2020 (10)

More Years

Publications
  1. Journal of Clinical Oncology (55)
  2. Journal of Thoracic Oncology (26)
  3. Clinical Cancer Research (17)
  4. Cancer (8)
  5. Annals of Thoracic Surgery (4)
  6. International Journal of Radiation Oncology, Biology, Physics (4)

More Publications

Publishers
  1. American Society of Clinical Oncology (59)
  2. Elsevier Inc. (34)
  3. American Association for Cancer Research (24)
  4. Oxford University Press (9)
  5. Wiley Blackwell (8)
  6. Elsevier Science, Inc. (6)

More Publishers

Results (168)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Tumor mutation burden and efficacy of EGFR-tyrosine kinase inhibitors in patients with EGFR-mutant lung cancers
    Journal Article

    Offin, M.; Rizvi, H.; Tenet, M.; Ni, A.; Sanchez-Vega, F.; Li, B. T.; Drilon, A.; Kris, M. G.; Rudin, C. M.; Schultz, N.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Pathologic assessment after neoadjuvant chemotherapy for NSCLC: Importance and implications of distinguishing adenocarcinoma from squamous cell carcinoma
    Journal Article

    Qu, Y.; Emoto, K.; Eguchi, T.; Aly, R. G.; Zheng, H.; Chaft, J. E.; Tan, K. S.; Jones, D. R.; Kris, M. G.; Adusumilli, P. S.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Outcomes after neoadjuvant or adjuvant chemotherapy for cT2-4N0-1 non–small cell lung cancer: A propensity-matched analysis
    Journal Article

    Brandt, W. S.; Yan, W.; Zhou, J.; Tan, K. S.; Montecalvo, J.; Park, B. J.; Adusumilli, P. S.; Huang, J.; Bott, M. J.; Rusch, V. W.; more...
    Journal of Thoracic and Cardiovascular Surgery (2019)

    Fulltext@MSK | Save
  • Afatinib in patients with metastatic or recurrent HER2-mutant lung cancers: A retrospective international multicentre study
    Journal Article

    Lai, W. V.; Lebas, L.; Barnes, T. A.; Milia, J.; Ni, A.; Gautschi, O.; Peters, S.; Ferrara, R.; Plodkowski, A. J.; Kavanagh, J.; more...
    European Journal of Cancer (2019)

    Fulltext@MSK | Save
  • Refining actionable HER2 alterations in lung cancers through next generation sequencing (NGS)
    Meeting Abstract

    Xu, C.; Myers, M.; Buonocore, D. J.; Razavi, P.; Shen, R.; Lai, W. C. V.; Smyth, L. M.; Zheng, T.; Ni, A.; Solit, D. B.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Prognostic relevance of tumor sequencing in metastatic lung adenocarcinomas
    Meeting Abstract

    Shen, R.; Martin, A.; Ni, A.; Hellmann, M. D.; Jordan, E.; Arora, A.; Ptashkin, R.; Zehir, A.; Kris, M. G.; Arbour, K. C.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • RET-rearranged lung cancers: Immunophenotype and response to immunotherapy
    Meeting Abstract

    Sabari, J. K.; Offin, M. D.; Wu, S. L.; Ni, A.; Halpenny, D.; Montecalvo, J.; Liu, D.; Pak, T. K.; Arbour, K. C.; Lai, W. C. V.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Tumor mutation burden and efficacy of targeted therapy in patients with EGFR mutant lung cancers
    Meeting Abstract

    Offin, M. D.; Rizvi, H.; Tenet, M.; Ni, A.; Sanchez Vega, F.; Kris, M. G.; Rudin, C. M.; Riely, G. J.; Yu, H. A.; Hellmann, M. D.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A multi-histology basket trial of ado-trastuzumab emtansine in patients with HER2 amplified cancers
    Meeting Abstract

    Li, B. T.; Makker, V.; Buonocore, D. J.; Offin, M. D.; Olah, Z. T.; Panora, E.; Shen, R.; Ho, A. L.; Yaeger, R.; Iyer, G.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • PD-L1 expression, tumor mutation burden and response to immune checkpoint blockade in patients with HER2-mutant lung cancers
    Meeting Abstract

    Lai, W. C. V.; Feldman, D. L.; Buonocore, D. J.; Brzostowski, E. B.; Rizvi, H.; Plodkowski, A. J.; Ni, A.; Sabari, J. K.; Offin, M. D.; Kris, M. G.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save